Sol-Gel Technologies Ltd.
Status: Publicly traded
Direct answer
Sol-Gel Technologies Ltd. is publicly traded on NASDAQ under the ticker SLGL.
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative,...
Can you invest in Sol-Gel Technologies Ltd.?
Yes. Sol-Gel Technologies Ltd. is publicly traded on NASDAQ under the ticker SLGL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sol-Gel Technologies Ltd.
Detailed equity research is provided by MarketSnap.